Brief: Rubius Therapeutics Reports Q3 Loss Per Share Of $0.51

Rubius Therapeutics

09/11/2020 14:33

Nov 9 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * RUBIUS THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
AND STRONG EXECUTION ACROSS THE PIPELINE
    * Q3 LOSS PER SHARE $0.51
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES
DATA
    * RUBIUS THERAPEUTICS -  AS OF SEPT 30, 2020, CASH, CASH
EQUIVALENTS AND INVESTMENTS WERE $207.9 MILLION PROVIDING RUBIUS
WITH A CASH RUNWAY INTO 2022

Source text for Eikon:  ID:nGNX2KgHf1 
Further company coverage:  RUBY.O 

 ((Reuters.Briefs@thomsonreuters.com;))